The Fort Worth Press - Pharma giants to pay $590 mn to US Native Americans over opioids

USD -
AED 3.673006
AFN 67.000311
ALL 92.449862
AMD 387.650577
ANG 1.803609
AOA 912.000072
ARS 998.1981
AUD 1.540618
AWG 1.8
AZN 1.706465
BAM 1.839835
BBD 2.020546
BDT 119.582702
BGN 1.851502
BHD 0.376887
BIF 2898
BMD 1
BND 1.337466
BOB 6.915139
BRL 5.806962
BSD 1.000762
BTN 84.395861
BWP 13.578807
BYN 3.274884
BYR 19600
BZD 2.01714
CAD 1.39948
CDF 2865.000212
CHF 0.885795
CLF 0.035513
CLP 979.90972
CNY 7.2244
CNH 7.244355
COP 4479
CRC 511.011392
CUC 1
CUP 26.5
CVE 104.849946
CZK 23.9373
DJF 177.719992
DKK 7.06055
DOP 60.375024
DZD 133.998993
EGP 49.3251
ERN 15
ETB 122.049964
EUR 0.94655
FJD 2.27125
FKP 0.786951
GBP 0.78699
GEL 2.730338
GGP 0.786951
GHS 16.093319
GIP 0.786951
GMD 71.000122
GNF 8629.999871
GTQ 7.732613
GYD 209.3638
HKD 7.781365
HNL 25.060257
HRK 7.133507
HTG 131.582908
HUF 386.059763
IDR 15845.9
ILS 3.754225
IMP 0.786951
INR 84.42365
IQD 1310.5
IRR 42092.500584
ISK 139.430268
JEP 0.786951
JMD 158.431955
JOD 0.7091
JPY 155.550045
KES 129.495865
KGS 86.200902
KHR 4049.999849
KMF 466.350132
KPW 899.999851
KRW 1402.789736
KWD 0.30764
KYD 0.833937
KZT 493.231612
LAK 21944.999787
LBP 89550.000237
LKR 292.48469
LRD 183.999896
LSL 18.249631
LTL 2.95274
LVL 0.60489
LYD 4.869392
MAD 9.95797
MDL 18.032417
MGA 4655.000074
MKD 58.249992
MMK 3247.960992
MNT 3397.999858
MOP 8.017648
MRU 39.875002
MUR 46.889881
MVR 15.450612
MWK 1735.999923
MXN 20.534202
MYR 4.459733
MZN 63.899729
NAD 18.250197
NGN 1677.460255
NIO 36.78002
NOK 11.139895
NPR 135.035137
NZD 1.70113
OMR 0.384979
PAB 1.000724
PEN 3.80195
PGK 3.93475
PHP 58.837965
PKR 278.049733
PLN 4.10935
PYG 7810.118723
QAR 3.64055
RON 4.7105
RSD 110.736994
RUB 98.498646
RWF 1365
SAR 3.75755
SBD 8.383555
SCR 13.638838
SDG 601.502988
SEK 10.984375
SGD 1.343089
SHP 0.786951
SLE 22.814981
SLL 20969.507172
SOS 571.500104
SRD 35.279997
STD 20697.981008
SVC 8.756103
SYP 2512.530016
SZL 18.249869
THB 34.941496
TJS 10.662352
TMT 3.51
TND 3.147501
TOP 2.3421
TRY 34.35113
TTD 6.800373
TWD 32.450501
TZS 2659.999506
UAH 41.343769
UGX 3672.521001
UYU 42.190719
UZS 12825.000122
VES 44.996698
VND 25345
VUV 118.721975
WST 2.812855
XAF 617.092513
XAG 0.033008
XAU 0.000389
XCD 2.70255
XDR 0.753908
XOF 616.50203
XPF 113.349685
YER 249.80406
ZAR 18.240398
ZMK 9001.201813
ZMW 27.374927
ZWL 321.999592
  • CMSC

    0.0700

    24.61

    +0.28%

  • SCS

    -0.3000

    13.37

    -2.24%

  • BCC

    1.4200

    142.55

    +1%

  • RBGPF

    -0.8500

    59.34

    -1.43%

  • CMSD

    -0.0200

    24.73

    -0.08%

  • NGG

    -0.7800

    62.12

    -1.26%

  • RIO

    -0.5800

    60.62

    -0.96%

  • JRI

    0.0200

    13.24

    +0.15%

  • BCE

    -0.4800

    27.21

    -1.76%

  • GSK

    -0.4100

    35.11

    -1.17%

  • RYCEF

    -0.0500

    7.11

    -0.7%

  • BTI

    0.1800

    35.42

    +0.51%

  • AZN

    0.1000

    65.29

    +0.15%

  • BP

    0.4100

    28.57

    +1.44%

  • RELX

    -0.4700

    46.12

    -1.02%

  • VOD

    0.2800

    8.75

    +3.2%

Pharma giants to pay $590 mn to US Native Americans over opioids
Pharma giants to pay $590 mn to US Native Americans over opioids

Pharma giants to pay $590 mn to US Native Americans over opioids

A group of pharmaceutical companies and distributors agreed to pay $590 million to settle lawsuits connected to opioid addiction among Native American tribes, according to a US court filing released Tuesday.

Text size:

The agreement is the latest amid a deluge of litigation spawned by the US opioid crisis, which has claimed more than 500,000 lives over the last 20 years and ensnared some of the largest firms in the world of American medicine.

The companies involved in the latest agreement include Johnson & Johnson and McKesson, according to a filing in an Ohio federal court by a committee of plaintiffs in the case.

Native Americans have "suffered some of the worst consequences of the opioid epidemic of any population in the United States," according to the filing from the Plaintiffs' Tribal Leadership Committee, which cited per-capita death rates compared with other ethnic groups.

"The burden of paying these increased costs has diverted scarce funds from other needs and has imposed severe financial burdens on the tribal plaintiffs."

Johnson & Johnson, McKesson and the other two companies in the accord -- AmerisourceBergen and Cardinal Health -- have previously agreed to a $26 billion global settlement on opioid cases.

J&J said Tuesday the $150 million it agreed to pay in the Native American case has been deducted from what it owes in the global settlement.

"This settlement is not an admission of any liability or wrongdoing and the company will continue to defend against any litigation that the final agreement does not resolve," the company said.

It was unclear if the other companies would take what they owe under the latest agreement from the global settlement.

- 'Measure of justice' -

Robins Kaplan, a law firm negotiating on the behalf of the plaintiffs, said in a statement the agreement must still be approved by the Native American tribes, which are pursuing other claims regarding opioids.

"This initial settlement for tribes in the national opioid litigation is a crucial first step in delivering some measure of justice to the tribes and reservation communities across the United States that have been ground zero for the opioid epidemic," Tara Sutton, an attorney at the firm who negotiated on behalf of the Native Americans.

Douglas Yankton, chairman of the North Dakota-based Spirit Lake Nation, said the money from the settlement would "help fund crucial, on-reservation, culturally appropriate opioid treatment services."

All tribes recognized by the US government, 574 in all, will be able to participate in the agreement, even if they have not filed lawsuits.

The settlement is separate from a prior agreement that resulted in $75 million in payments to the Cherokee Nation from three distribution companies, including McKesson.

Many of the lawsuits regarding the opioid crisis have centered on Purdue Pharma, the manufacturer of OxyContin, a highly addictive prescription painkiller blamed for causing a spike in addiction.

A judge in December overturned the company's bankruptcy plan because it provided some immunity for the owners of the company in exchange for a $4.5 billion payout to victims of the opioid crisis.

The litigation wave has also swamped pharmacies owned by Walmart, Walgreens and CVS, which a jury found in November bear responsibility for the opioid crisis in two counties in Ohio.

C.M.Harper--TFWP